Iran Vows No Concession as Trump Rejects Peace Offer Prolonging Market Uncertainty Endava DAVA Q1 2026 Earnings EPS 016 Beats Estimates Why Andy Burnhams Potential Rise to UK Prime Minister Is Rattling Investors Leggett LEG Q1 2026 Earnings Miss EPS 015 vs 024 Expected Quiz Set to Shut All Stores After 33 Years Amid Intensifying Retail Challenges NYT Pips Puzzle Hints and Answers Released Potential Impact on Digital Engagement Meta Rolls Out AI Subscription Plans Starting at 799 Monthly in New Testing Phase Plus500 Reports 11 Quarterly Revenue Growth Reaffirms FullYear Guidance Entrepreneurs Overestimate AI Advantage as Competitors Quietly Gain Edge SEBI Bars Seven Family Members for Social Media Stock Manipulation Alleges 2025 Crore Illegal Gains RMR Q1 2026 Earnings EPS Misses Estimates Amid Flat Revenue Disclosure SBAC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Leasing Environment FRMEP Q1 2026 Earnings EPS Surpasses Estimates by 895 SRBK Q3 2025 Earnings Positive EPS of 006 Stock Advances 243 ALGN Q1 2026 Earnings EPS Beats Estimates by 1096 Revenue Not Disclosed Sunstone Hotel Investors Inc SHO Q1 2026 Earnings Strong EPS Surprise of 98 Outperforms Estimates Despite Stock Dip Inovio Pharmaceuticals INO Holds Near Support Amid Slight Decline Calavo Growers CVGW Holds Steady Amid Consolidation Support and Resistance in Focus Simon Property Group SPG Holds Near 204 Amid Quiet Trading Key Levels in Focus Werner Enterprises WERN Holds Steady Near Support Amid Flat Trading Viemed Healthcare VMD Edges Higher as Stock Holds Above Key Support Level AKTS Q1 2026 Earnings ClinicalStage Biotech Posts WiderThanExpected Loss Shares Edge Higher FULTP Q1 2026 Earnings Preferred Stock Delivers EPS Beat Despite Market Headwinds MDLZ Q1 2026 Earnings EPS Beats Estimates by 81 as Snacking Giant Navigates Cost Pressures Akebia Therapeutics AKBA Q1 2026 Earnings EPS Misses Estimates Amidst Flat Stock Reaction SION Q1 2026 Earnings ClinicalStage Biotech Misses Estimates with Wider Net Loss Bond Market Signals Inflation Concerns as New Fed Leadership Takes Over MNDO Q1 2025 Earnings Modest Profitability Drives Positive Stock Reaction Plains GP Holdings PAGP Edges Lower as Support Levels Come into Focus NIO Inc NIO Expands Budget Brand with New L80 SUV Intensifying Competition with Tesla in China Great GSBC Stock Fiscal Policy 001 20260427 Eli Lilly and Company LLY Announces 23B Planned Acquisition of Ajax Therapeutics to Bolster Hematological Oncology Pipeline Lexaria Bioscience LEXX retreats 5 despite EPS beating estimates by 38 with 52 revenue growth ORIC Oric Pharmaceuticals posts narrower than expected Q4 2025 loss shares rise 466 percent in todays trading Heron Therapeutics HRTX Stock Strategic Buy or Not Q4 2025 Profit Surprises iShares Latin America 40 ETF ILF Emerging Market Leadership Amid Narrow 2026 Market Breadth